One surgeon's preference for an ophthalmic viscosurgical device of 1.6% sodium hyaluronate was reinforced by a study that found it superior to another OVD during phaco and OVD removal
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.